Cipla
Search results
Mobile computing is. future. Business is no more restricted to 4 walls. Proteus Vision is with you always, as an app on your phone. Allows you to perform your important business tasks, anytime, anywhere.
sunpharmashine.com
future NOW. Business is no more restricted to 4 walls. Proteus Vision is with you always, as an app on your phone. Allows you to perform your important business tasks, anytime, anywhere. Did we say important tasks? Yes, you can configure what is important for you and you will receive alerts only for these tasks. User ID. Password.
Welcome to MySunPharma! Please login below with your username and password.
Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries. Subscribe on YouTube. Sun Pharma Story.
Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US$ 5.4 billion. Supported by 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries.
Sun Pharma is the No. 1 and largest pharmaceutical company in India with over 8% market share in the domestic market (AIOCD AWACS for 12 months ending Sept 2023). The company has been ranked No. 1 with over 12 different classes of doctors (SMSRC Prescription Data).
Founded in 1983, India's largest pharma company Sun Pharma saw some of its toughest times between 2014 and 2018. However, under Dilip Shanghvi, Sun Pharma saw a turnaround. Watch this...
Jul 11, 2023 · Under Dilip Shanghvi, Sun Pharmaceutical Industries Limited, India’s largest pharma company, is building additional engines of growth with an eye on the future, especially the specialty...
